Rune Bergman
Chief Executive Officer en Nordvacc Läkemedel AB .
Perfil
Rune Bergman was the founder of Intervacc AB, where he held the title of Chairman & Sales Director from 2001 to 2018.
He is currently the Chief Executive Officer at Nordvacc Läkemedel AB.
Dr. Bergman received a doctorate degree from the Swedish University of Agricultural Sciences in 1981.
Cargos activos de Rune Bergman
| Empresas | Cargo | Inicio |
|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Chief Executive Officer | - |
Antiguos cargos conocidos de Rune Bergman.
| Empresas | Cargo | Fin |
|---|---|---|
| INTERVACC AB | Founder | 30/06/2019 |
Formación de Rune Bergman.
| Swedish University of Agricultural Sciences | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Bolsa de valores
- Insiders
- Rune Bergman
